Results 251 to 260 of about 774,384 (405)
Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis
Rheumatoid arthritis is a complex systemic disorder characterised primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease e.g. of the lung with potentially devastating clinical consequences.
Aurelie Najm +2 more
wiley +1 more source
Factors associated with interstitial lung disease among patients with idiopathic inflammatory myopathies. [PDF]
Wilkerson JC +8 more
europepmc +1 more source
Role of nocturnal oxygen therapy in interstitial lung disease with obstructive sleep apnoea syndrome
Dimple Shah, Jyotsna Joshi
openalex +1 more source
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) utilizing three independent cohorts.
Brent A. Luedders +18 more
wiley +1 more source
Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort. [PDF]
McGroder CF +12 more
europepmc +1 more source
Defining Interstitial Lung Disease Progression: It Is Time to (Get Our) Act Together
Vanessa Smith +2 more
openalex +2 more sources
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang +6 more
wiley +1 more source
Interstitial Lung Disease in 2025-Progress, Challenges, and Hope Ahead. [PDF]
Sehgal S, Mehta A.
europepmc +1 more source
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no FDA‐approved disease‐modifying therapies for SjD.
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama +16 more
wiley +1 more source

